FROM CLINICAL TRIALS TO REAL-WORLD EVIDENCE: SIMILAR VIROLOGIC CURE RATES AND SAFETY OUTCOMES FOLLOWING TREATMENT WITH GLECAPREVIR/PIBRENTASVIR AMONG PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION AND RECENT DRUG USE

被引:0
|
作者
Aghemo, Alessio [1 ]
Negro, Francesco [2 ]
Gschwantler, Michael [3 ,4 ]
Asselah, Tarik [5 ]
Bondin, Mark I. [6 ]
Crown, Eric D. [6 ]
Mancine, Miki [6 ]
Zhang, Zhenzhen [6 ]
Flisiak, Robert [7 ]
Grebely, Jason [8 ]
Brau, Norbert [9 ,10 ]
Sterling, Richard K. [11 ]
机构
[1] Humanitas Univ & Res Hosp, Milan, Italy
[2] Univ Geneva, Geneva, Switzerland
[3] Wilhelminenspital Stadt Wien, Dept Internal Med 4, Vienna, Austria
[4] Sigmund Freud Univ, Vienna, Austria
[5] Univ Paris Diderot, Hop Beaujon, AP HP,Dept Hepatol, Ctr Rech Inflammat,Viral Hepatitis,Inserm,Umr 114, Clichy, France
[6] Abbvie Inc, N Chicago, IL USA
[7] Med Univ Bialystok, Dept Infect Dis & Hepatol, Bialystok, Poland
[8] Unsw Sydney, Kirby Inst, Sydney, NSW, Australia
[9] Icahn Sch Med Mt Sinai, Dept Med, Div Infect Dis & Liver Dis, New York, NY 10029 USA
[10] James J Peters Vet Affairs Med Ctr, Infect Dis Sect, Bronx, NY USA
[11] Virginia Commonwealth Univ, Dept Internal Med, Div Gastroenterol Hepatol & Nutr, Richmond, VA 23284 USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1549
引用
收藏
页码:932A / 933A
页数:2
相关论文
共 50 条
  • [41] Real-world virological efficacy and safety of elbasvir and grazoprevir in patients with chronic hepatitis C virus genotype 1 infection in Japan
    Toyoda, Hidenori
    Atsukawa, Masanori
    Takaguchi, Koichi
    Senoh, Tomonori
    Michitaka, Kojiro
    Hiraoka, Atsushi
    Fujioka, Shinichi
    Kondo, Chisa
    Okubo, Tomomi
    Uojima, Haruki
    Tada, Toshifumi
    Yoneyama, Hirohito
    Watanabe, Tsunamasa
    Asano, Toru
    Ishikawa, Toru
    Tamai, Hideyuki
    Abe, Hiroshi
    Kato, Keizo
    Tsuji, Kunihiko
    Ogawa, Chikara
    Shimada, Noritomo
    Iio, Etsuko
    Deguchi, Akihiro
    Itobayashi, Ei
    Mikami, Shigeru
    Moriya, Akio
    Okubo, Hironao
    Tani, Joji
    Tsubota, Akihito
    Tanaka, Yasuhito
    Masaki, Tsutomu
    Iwakiri, Katsuhiko
    Kumada, Takashi
    JOURNAL OF GASTROENTEROLOGY, 2018, 53 (12) : 1276 - 1284
  • [42] GRAND PLAN: Safety and Efficacy of Glecaprevir/Pibrentasvir for the Treatment of Hepatitis C Virus Infection Among People Initially Disengaged From Health Care Who Use Drugs-A Systematic Multidisciplinary Approach
    Conway, Brian
    Yi, Shana
    Yung, Rossitta
    Sharma, Shawn
    OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (03):
  • [43] Impact of a simplified diagnosis-monitoring strategy on Glecaprevir/Pibrentasvir (G/P) treatment initiation and response in patients with chronic hepatitis C virus (HCV) infection receiving opioid substitute therapy in Israel-a real world evidence
    Zuckerman, Eli
    Azulay, Orly
    JOURNAL OF HEPATOLOGY, 2024, 80 : S834 - S835
  • [44] Suboptimal Treatment Rates and Treatment Completion Rates of Chronic Hepatitis C Virus Therapy in Patients with Comorbidities: Analysis of a Large Real-World US Cohort
    Nguyen, Mindie H.
    Brooks, Louis
    Livornese, Richard C.
    HEPATOLOGY, 2013, 58 : 1194A - 1195A
  • [45] Real-world treatment outcome of direct-acting antivirals and patient survival rates in chronic hepatitis C virus infection in Eritrea
    Ghirmay Ghebrekidan Ghebremeskel
    Michael Berhe Solomon
    Oliver Okoth Achila
    Samuel Tekle Mengistu
    Rahel Frezghi Asmelash
    Araia Berhane Mesfin
    Mohammed Elfatih Hamida
    Scientific Reports, 13
  • [46] Real-world treatment outcome of direct-acting antivirals and patient survival rates in chronic hepatitis C virus infection in Eritrea
    Ghebremeskel, Ghirmay Ghebrekidan
    Solomon, Michael Berhe
    Achila, Oliver Okoth
    Mengistu, Samuel Tekle
    Asmelash, Rahel Frezghi
    Mesfin, Araia Berhane
    Hamida, Mohammed Elfatih
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [47] Real-world virological efficacy and safety of daclatasvir/asunaprevir/beclabuvir in patients with chronic hepatitis C virus genotype 1 infection in Japan
    Takaguchi, Koichi
    Toyoda, Hidenori
    Tsutsui, Akemi
    Suzuki, Yoshiyuki
    Nakamuta, Makoto
    Imamura, Michio
    Senoh, Tomonori
    Nagano, Takuya
    Tada, Toshifumi
    Tachi, Yoshihiko
    Hiraoka, Atsushi
    Michitaka, Kojiro
    Shibata, Hiroshi
    Joko, Kouji
    Okubo, Hironao
    Tsuji, Kunihiko
    Takaki, Shintaro
    Watanabe, Tsunamasa
    Ogawa, Chikara
    Chayama, Kazuaki
    Kumada, Takashi
    Kudo, Masatoshi
    Kumada, Hiromitsu
    JOURNAL OF GASTROENTEROLOGY, 2019, 54 (08) : 742 - 751
  • [48] Real-World Virological Efficacy and Safety of Ledipasvir and Sofosbuvir in Patients with Chronic Hepatitis C Virus Genotype 2 Infection: A Multicenter Study
    Tada, Toshifumi
    Kumada, Takashi
    Okushin, Hiroaki
    Tani, Joji
    Takaguchi, Koichi
    Tsutsui, Akemi
    Toyoda, Hidenori
    Yasuda, Satoshi
    Dohmen, Kazufumi
    Hiraoka, Atsushi
    Michitaka, Kojiro
    Nouso, Kazuhiro
    Kariyama, Kazuya
    Kim, Soo Ryang
    Kim, Soo Ki
    Fujioka, Shinichi
    Mikami, Shigeru
    Watanabe, Yuto
    Tamai, Tsutomu
    Atsukawa, Masanori
    Itokawa, Norio
    Tanaka, Hironori
    Tsuji, Kunihiko
    Ishikawa, Toru
    Imai, Michitaka
    Itobayashi, Ei
    Shibata, Hiroshi
    Shimada, Noritomo
    INFECTIOUS DISEASES AND THERAPY, 2021, 10 (01) : 269 - 280
  • [49] Real-World Virological Efficacy and Safety of Ledipasvir and Sofosbuvir in Patients with Chronic Hepatitis C Virus Genotype 2 Infection: A Multicenter Study
    Toshifumi Tada
    Takashi Kumada
    Hiroaki Okushin
    Joji Tani
    Koichi Takaguchi
    Akemi Tsutsui
    Hidenori Toyoda
    Satoshi Yasuda
    Kazufumi Dohmen
    Atsushi Hiraoka
    Kojiro Michitaka
    Kazuhiro Nouso
    Kazuya Kariyama
    Soo Ryang Kim
    Soo Ki Kim
    Shinichi Fujioka
    Shigeru Mikami
    Yuto Watanabe
    Tsutomu Tamai
    Masanori Atsukawa
    Norio Itokawa
    Hironori Tanaka
    Kunihiko Tsuji
    Toru Ishikawa
    Michitaka Imai
    Ei Itobayashi
    Hiroshi Shibata
    Noritomo Shimada
    Infectious Diseases and Therapy, 2021, 10 : 269 - 280
  • [50] Real-world virological efficacy and safety of daclatasvir/asunaprevir/beclabuvir in patients with chronic hepatitis C virus genotype 1 infection in Japan
    Koichi Takaguchi
    Hidenori Toyoda
    Akemi Tsutsui
    Yoshiyuki Suzuki
    Makoto Nakamuta
    Michio Imamura
    Tomonori Senoh
    Takuya Nagano
    Toshifumi Tada
    Yoshihiko Tachi
    Atsushi Hiraoka
    Kojiro Michitaka
    Hiroshi Shibata
    Kouji Joko
    Hironao Okubo
    Kunihiko Tsuji
    Shintaro Takaki
    Tsunamasa Watanabe
    Chikara Ogawa
    Kazuaki Chayama
    Takashi Kumada
    Masatoshi Kudo
    Hiromitsu Kumada
    Journal of Gastroenterology, 2019, 54 : 742 - 751